Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Research & Development: 2023-2024

Historic Research & Development for Biofrontera (BFRI) over the last 2 years, with Dec 2024 value amounting to $2.1 million.

  • Biofrontera's Research & Development rose 27.65% to $854,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 177.16%. This contributed to the annual value of $2.1 million for FY2024, which is 2612.99% up from last year.
  • Latest data reveals that Biofrontera reported Research & Development of $2.1 million as of FY2024, which was up 2,612.99% from $77,000 recorded in FY2023.
  • Biofrontera's Research & Development's 5-year high stood at $2.1 million during FY2024, with a 5-year trough of $77,000 in FY2023.
  • Moreover, its 2-year median value for Research & Development was $1.1 million (2023), whereas its average is $1.1 million.
  • Data for Biofrontera's Research & Development shows a peak YoY spiked of 2,612.99% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Biofrontera's Research & Development stood at $77,000 in 2023, then skyrocketed by 2,612.99% to $2.1 million in 2024.